In a study analyzing the spatial distribution of infiltrating immune cells in mismatch repair-deficient colorectal cancer treated with anti-PD-1 therapy, the number of PD-1+ cells located within 10 μm of PD-L1+ cells was found to be a useful predictor of progression-free survival 29. The gene discussed is PDCD1; the disease is colorectal cancer.